Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Patelli

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Cancer Treatment Reviews|October 22, 2020
Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunitiesGianluca Mauri, Viviana Gori, Erica Bonazzina, et al.
Targeted Oncology|March 19, 2021
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNAGiorgio Patelli, Caterina Vaghi, Federica Tosi, et al.
Targeted Oncology|March 31, 2021
Correction to: Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNAGiorgio Patelli, Caterina Vaghi, Federica Tosi, et al.
Eclinicalmedicine|April 9, 2026
Locally advanced rectal cancer: what patients and practitioners should know about non-operative managementFederica Tosi, Giorgio Patelli, Pietro Carnevali, et al.
Frontiers in Oncology|November 24, 2022
Case Report: <i>MAP2K1 K57N</i> mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancerGianluca Mauri, Giorgio Patelli, Viviana Gori, et al.
Frontiers in Oncology|April 14, 2023
Corrigendum: Case report: <i>MAP2K1 K57N</i> mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancerGianluca Mauri, Giorgio Patelli, Viviana Gori, et al.
Clinical Colorectal Cancer|March 22, 2024
Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal CancerLaura Roazzi, Giorgio Patelli, Katia Bruna Bencardino, et al.
Journal of Medical Case Reports|February 2, 2021
Chemotherapy-induced myasthenic crisis in thymoma treated with primary chemotherapy with curative intent on mechanical ventilation: a case report and review of the literatureGiorgio Patelli, Katia Bencardino, Federica Tosi, et al.
Cancer Treatment Reviews|September 10, 2019
Liquid biopsy for rectal cancer: A systematic reviewDaniela Massihnia, Elio Gregory Pizzutilo, Alessio Amatu, et al.
Cancer Treatment Reviews|March 9, 2025
Circulating blood biomarkers for minimal residual disease in hepatocellular carcinoma: A systematic reviewEdoardogregorio Galli, Giorgio Patelli, Federica Villa, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cancer Treatment Reviews|October 22, 2020
Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunitiesGianluca Mauri, Viviana Gori, Erica Bonazzina, et al.
Targeted Oncology|March 19, 2021
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNAGiorgio Patelli, Caterina Vaghi, Federica Tosi, et al.
Targeted Oncology|March 31, 2021
Correction to: Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNAGiorgio Patelli, Caterina Vaghi, Federica Tosi, et al.
Eclinicalmedicine|April 9, 2026
Locally advanced rectal cancer: what patients and practitioners should know about non-operative managementFederica Tosi, Giorgio Patelli, Pietro Carnevali, et al.
Frontiers in Oncology|November 24, 2022
Case Report: <i>MAP2K1 K57N</i> mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancerGianluca Mauri, Giorgio Patelli, Viviana Gori, et al.
Frontiers in Oncology|April 14, 2023
Corrigendum: Case report: <i>MAP2K1 K57N</i> mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancerGianluca Mauri, Giorgio Patelli, Viviana Gori, et al.
Clinical Colorectal Cancer|March 22, 2024
Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal CancerLaura Roazzi, Giorgio Patelli, Katia Bruna Bencardino, et al.
Journal of Medical Case Reports|February 2, 2021
Chemotherapy-induced myasthenic crisis in thymoma treated with primary chemotherapy with curative intent on mechanical ventilation: a case report and review of the literatureGiorgio Patelli, Katia Bencardino, Federica Tosi, et al.
Cancer Treatment Reviews|September 10, 2019
Liquid biopsy for rectal cancer: A systematic reviewDaniela Massihnia, Elio Gregory Pizzutilo, Alessio Amatu, et al.
Cancer Treatment Reviews|March 9, 2025
Circulating blood biomarkers for minimal residual disease in hepatocellular carcinoma: A systematic reviewEdoardogregorio Galli, Giorgio Patelli, Federica Villa, et al.
Pageof 3